Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 03, 2023

BUY
$10.88 - $20.05 $158,021 - $291,206
14,524 Added 9.35%
169,926 $1.94 Million
Q3 2022

Oct 28, 2022

BUY
$16.06 - $26.39 $312,559 - $513,602
19,462 Added 14.32%
155,402 $2.65 Million
Q2 2022

Aug 04, 2022

BUY
$20.49 - $39.72 $614,700 - $1.19 Million
30,000 Added 28.32%
135,940 $2.92 Million
Q1 2022

Apr 26, 2022

BUY
$28.19 - $46.6 $815,874 - $1.35 Million
28,942 Added 37.59%
105,940 $3.92 Million
Q4 2021

Feb 18, 2022

BUY
$41.2 - $73.6 $3.17 Million - $5.67 Million
76,998 New
76,998 $3.5 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Efg Asset Management (North America) Corp. Portfolio

Follow Efg Asset Management (North America) Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Asset Management (North America) Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Asset Management (North America) Corp. with notifications on news.